Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FM8HP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,273
Award facts
- Contract value 100% obligated
- $10,273.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,273.38 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml autoinjector units. This firm fixed-price delivery order, issued on August 26, 2025, represents a continuation of pharmaceutical supply services under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract will be completed by September 17, 2025, with performance based in Park Ridge, Illinois. No set-aside designation was utilized for this award.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, holds a significant single-award IDC with DLA valued at $499,999,999 through November 2026 under the SPE2DB program. This master contract enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide, including branded and generic prescription drugs, biologics, and medical consumables. As a registered federal contractor since 2001, DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering specialized medications and medical supplies directly to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FM8HP?
SPE2DB25FM8HP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FM8HP worth?
The government has obligated $10,273 on SPE2DB25FM8HP.
Is contract SPE2DB25FM8HP an order under another contract?
Yes. SPE2DB25FM8HP is a delivery order under SPE2DB22D9151, an indefinite delivery contract.
Was contract SPE2DB25FM8HP competed?
The extent of competition for SPE2DB25FM8HP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award